July 15, 2022
Healio recently published an article featuring research from Rena Conti, Associate Professor of Markets, Public Policy, and Law, on the prices of epinephrine autoinjectors, which are used to combat life-threatening allergic reactions, remaining high for many depending on insurance.
In a study measuring 657,813 patients enrolled in epinephrine autoinjector fills, Rena and Kao-Ping Chua, MD, PhD, examined employer-sponsored insurance claims. They found that generic autoinjector brands preserved efficacy but at a lower price, leading them to advise doctors to prescribe nonbranded autoinjectors to their patients. Kao-Ping emphasized this point, saying that, “to mitigate these problems, doctors should prescribe the epinephrine autoinjector with the lowest list price when deciding between products.”
Ultimately, Rena and her co-author argue that with the availability of lower-priced drugs, patient out-of-pocket spending will likely decrease.
- [BU Today] Questrom Sustainability Competition, with $50,000 Prize, Draws 62 Student Teams from 12 Schools
- The Changing Role of Business in Society
- S1:E1 CVS Paying the “Pink Tax” on Certain Products and the Evolution of the Electric Vehicle Industry
- Gender Differences and the Job Search
- [Boston Herald] Powerball Jackpot Soars: Expert Says What Winner Should Do
- How winning record $2 billion Powerball jackpot could still lead to bankruptcy
- [BU Today] Beyond Bitcoin: Why Interest in Blockchain is Surging at BU
- [Things I Didn’t Learn at Harvard] Do This One Thing Each Year
- [NY Post] Why Bank Robbing has Gone Out of Style
- To Encourage Patients to Fill Prescriptions, Fix Copays